BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16568881)

  • 1. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kos M; Kuebler JF; Luczak K; Engelke W
    J Craniomaxillofac Surg; 2010 Jun; 38(4):255-9. PubMed ID: 19592261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
    Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
    J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
    Melo MD; Obeid G
    J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
    Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
    Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaws.
    Yeo AC; Lye KW; Poon CY
    Singapore Dent J; 2005 Dec; 27(1):36-40. PubMed ID: 16438267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L; Junquera L
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-induced osteonecrosis of the jaws.
    Throndson RR; Healy SM; Zwickey MR
    Tex Dent J; 2005 Sep; 122(9):960-5. PubMed ID: 16320503
    [No Abstract]   [Full Text] [Related]  

  • 12. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
    Gueiros LA; Lopes MA; Leão JC
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
    Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
    Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws.
    Biasotto M; Chiandussi S; Dore F; Rinaldi A; Rizzardi C; Cavalli F; Di Lenarda R
    Acta Odontol Scand; 2006 Nov; 64(6):348-54. PubMed ID: 17123911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
    Tsai WS; Haghighi K; Placa SJ
    Gen Dent; 2006; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants].
    Savoldelli C; Le Page F; Santini J; Scortecci G; Odin G
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):555-8. PubMed ID: 17631371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
    Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
    J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.